Motus GI Receives FDA Clearance to Commercialize Pure-Vu EVS Gastro and Gen 4 Colon
24 oct. 2023 08h00 HE
|
Motus GI Holdings, Inc.
– Clearance opens up the potential breakthrough opportunity in the Upper GI market, an area of high unmet clinical need – – Technological advancements featured in new generation of the Pure-Vu...
Motus GI Submits Special 510(k) to FDA for Pure-Vu EVS Gen 4 Gastro and Colon
26 sept. 2023 08h00 HE
|
Motus GI Holdings, Inc.
– A special 510(k), according to FDA guidance, is usually reviewed within 30 days of receipt – – Pure-Vu Gen 4 platform opens up the Upper GI market, reduces the cost-of-goods by approximately 50%...
Motus GI Amends Royalty Agreement
14 sept. 2023 16h05 HE
|
Motus GI Holdings, Inc.
– Amended agreement eliminates approximately $1.0M in contingent royalty obligations from balance sheet – – Canceled royalty rights in exchange for common stock expected to improve Company’s...
Motus GI Appoints Medical Device Industry Veteran Scott Durbin to its Board of Directors
06 sept. 2023 17h00 HE
|
Motus GI Holdings, Inc.
FORT LAUDERDALE, Fla., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company focused on improving endoscopic outcomes...
Motus GI to Present at the H.C. Wainwright 25th Annual Global Investment Conference
24 août 2023 16h05 HE
|
Motus GI Holdings, Inc.
FORT LAUDERDALE, Fla., Aug. 24, 2023 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company focused on improving endoscopic outcomes...
Motus GI Reports Second Quarter 2023 Financial Results and Provides Corporate Update
14 août 2023 16h01 HE
|
Motus GI Holdings, Inc.
On track to submit planned special 510(k) for Pure-Vu Gen 4 Gastro and Colon to the FDA in Q4 2023;Received system wide approval in the Banner Medical Hospital Network and installed the first system...
Motus GI Receives Approval from the Israeli Ministry of Health to Initiate Commercial Sales of its Pure-Vu® EVS System
10 août 2023 09h00 HE
|
Motus GI Holdings, Inc.
FORT LAUDERDALE, Fla., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company focused on improving endoscopic outcomes...
Motus GI Announces Purchase Agreement for the Pure-Vu System® from Banner Desert Medical Center
20 juil. 2023 08h00 HE
|
Motus GI Holdings, Inc.
Implementation of the Pure-Vu system designed to improve efficiencies and outcomes of GI endoscopy proceduresInitial agreement expected to provide an easier sales process to the other more than 30...
Motus GI Announces Pure-Vu Gen 4 Gastro and Colon System Featured at 9th IECED Live Endoscopy Course 2023 at the Pentax Learning Center
14 juin 2023 08h00 HE
|
Motus GI Holdings, Inc.
Pure-Vu system featured in live case during an underwater large polyp resection in the colonOver 1,000 physicians registered for IECED Live Endoscopy Course from across Latin AmericaPure-Vu Gen 4...
Motus GI Announces Appointment of Ravit Ram as Chief Financial Officer
05 juin 2023 16h42 HE
|
Motus GI Holdings, Inc.
Company completes corporate reorganization focused on reducing operating costs while supporting key value creation drivers, including seeking key FDA approvals and pursuit of strategic partnerships to...